Crystal structure of the PIM2 kinase in complex with an organoruthenium inhibitor.
BACKGROUND
The serine/threonine kinase PIM2 is highly expressed in human leukemia and lymphomas and has been shown to positively regulate survival and proliferation of tumor cells. Its diverse ATP site makes PIM2 a promising target for the development of anticancer agents. To date our knowledge of catalytic domain structures of the PIM kinase family is limited to PIM1 which has been extensively studied and which shares about 50% sequence identity with PIM2.


RESULTS
Here we determined the crystal structure of PIM2 in complex with an organoruthenium complex (inhibition in sub-nanomolar level). Due to its extraordinary shape complementarity this stable organometallic compound is a highly potent inhibitor of PIM kinases.


CONCLUSIONS
The structure of PIM2 revealed several differences to PIM1 which may be explored further to generate isoform selective inhibitors. It has also demonstrated how an organometallic inhibitor can be adapted to the binding site of protein kinases to generate highly potent inhibitors.


BACKGROUND
This article can also be viewed as an enhanced version in which the text of the article is integrated with interactive 3D representations and animated transitions. Please note that a web plugin is required to access this enhanced functionality. Instructions for the installation and use of the web plugin are available in Text S1.
Bullock
Alex N
AN
University of Oxford, Structural Genomics Consortium, Oxford, United Kingdom.
Russo
Santina
S
Amos
Ann
A
Pagano
Nicholas
N
Bregman
Howard
H
Debreczeni
Judit E
JE
Lee
Wen Hwa
WH
von Delft
Frank
F
Meggers
Eric
E
Knapp
Stefan
S
D001665:Binding Sites; D002626:Chemistry, Pharmaceutical / Q000379:methods; D018360:Crystallography, X-Ray / Q000379:methods; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000737:chemistry*; D006801:Humans; D015394:Molecular Structure; D011487:Protein Conformation; D020033:Protein Isoforms; D017434:Protein Structure, Tertiary; D051573:Proto-Oncogene Proteins c-pim-1 / Q000737:chemistry*; D012428:Ruthenium / Q000737:chemistry*; D019311:Staurosporine / Q000737:chemistry; D013329:Structure-Activity Relationship
D004791:Enzyme Inhibitors; D020033:Protein Isoforms; D012428:Ruthenium; D051573:Proto-Oncogene Proteins c-pim-1; C406031:proto-oncogene proteins pim; D019311:Staurosporine